News Column

Story stocks

June 30, 2014

Micron Technology



% chg:+4.6%

Day's high/low:


Credit Suisse added the memory chipmaker to its "focus list," putting a $50 price target on the stock. The brokerage is bullish on Micron's potential to boost margins, as well as its diversification.


The Food and Drug Administration raised issues about the drugmaker's application for a new acute migraine treatment. Allergan is trying to evade a hostile takeover by Valeant Pharmaceuticals.

D.R. Horton

Barclays raised its price target on the homebuilder's stock from $28 to $34, partly because of a jump in pending home sales. Horton enjoys revenue growth that outpaces the industry average, Barclays said.

For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: USA Today

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters